enVVeno Medical Corp (NVNO)
4.99
+0.04
(+0.81%)
USD |
NASDAQ |
May 17, 16:00
4.99
0.00 (0.00%)
After-Hours: 20:00
enVVeno Medical Cash from Financing (Quarterly): 0.046M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.046M |
December 31, 2023 | 25.79M |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | 0.00 |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | -0.004M |
September 30, 2021 | 19.24M |
June 30, 2021 | 0.00 |
March 31, 2021 | 38.37M |
December 31, 2020 | 6.347M |
September 30, 2020 | 5.872M |
Date | Value |
---|---|
June 30, 2020 | 2.286M |
March 31, 2020 | 0.5703M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 3.320M |
March 31, 2019 | 2.317M |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 7.174M |
March 31, 2018 | 1.857M |
December 31, 2017 | 0.9684M |
September 30, 2017 | 1.381M |
June 30, 2017 | 1.230M |
March 31, 2017 | 0.4789M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.004M
Minimum
Dec 2021
38.37M
Maximum
Mar 2021
7.274M
Average
1.428M
Median
Cash from Financing (Quarterly) Benchmarks
Align Technology Inc | -11.72M |
ThermoGenesis Holdings Inc | 0.217M |
NeuroOne Medical Technologies Corp | 1.205M |
SINTX Technologies Inc | 5.328M |
Nutriband Inc | -0.005M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -3.549M |
Cash from Investing (Quarterly) | 2.197M |
Free Cash Flow | -17.34M |
Free Cash Flow Per Share (Quarterly) | -0.2216 |
Free Cash Flow Yield | -25.72% |